IV therapy standing order compliance looks very different in 2026 than it did even a year ago, and that shift can catch clinic owners off guard. If your IV clinic is still running on a generic standing order — the kind where a medical director signs off once and your staff administers the same menu to anyone who walks in — 2026 is the year that model stops being legal in a growing number of states. This isn’t a slow-moving trend you can watch from a distance. Texas, Kansas, California, and Georgia have all taken direct regulatory action this year specifically targeting the standing-order model that much of this industry was built on. Other states are expected to follow the same pattern. If you haven’t reviewed your standing orders since before 2026, there’s a real chance you’re already out of step with where enforcement is heading — even if nothing has happened to your clinic yet.
Why IV Therapy Standing Order Compliance Rules Are Tightening
For years, the standard IV bar model worked like this: a medical director signs a broad set of protocols once, and from that point forward, nurses or techs can administer any treatment on the menu to any patient who fills out an intake form and signs a waiver. No individualized exam. No real-time physician involvement per visit.
Regulators have increasingly concluded that this model doesn’t reflect how medical decisions are supposed to be made. IV therapy puts fluids, vitamins, and sometimes medications directly into a patient’s bloodstream — and boards are now treating that as a genuine medical decision that has to be made by a licensed prescriber, for that specific patient, at that specific visit. A signature on a protocol from six months ago doesn’t meet that bar anymore in an increasing number of states.
State-by-State: What’s Actually Changed
Texas — Texas enacted IV-specific legislation, widely referred to as Jenifer’s Law, which took full effect in September 2025 and reached its first complete enforcement cycle in early 2026. The law requires a documented, individualized assessment and a specific order from a physician or another provider with prescriptive authority before each IV session — effectively eliminating the pre-approved menu where patients could select a treatment without a doctor reviewing their history first. Clinics found relying on a generic protocol face shutdown, and supervising physicians risk license action.
Kansas — In a joint statement issued by its medical and pharmacy boards in early 2026, Kansas regulators declared that IV administration of any substance — including plain saline, amino acids, or minerals — constitutes the practice of the healing arts. The statement specifically flags pre-set treatment menus as non-compliant, and reclassifies on-site mixing of additives into a saline bag as drug compounding, which generally requires a pharmacist or a pre-mixed product from a licensed outsourcing facility. This is one of the more aggressive interpretations nationally, and it directly targets a practice most IV bars have relied on since the industry began.
California — Through enforcement of SB 351 and AB 1415, California has moved to prohibit the generic standing order outright. In its place, regulators are requiring a Patient-Specific Order for every treatment — meaning a physician, nurse practitioner, or physician assistant must conduct a real-time encounter (in person or via compliant telehealth) before each infusion, not just once at onboarding. California is also scrutinizing management arrangements to confirm medical directors are providing genuine, active oversight rather than a name on a contract.
Georgia — The Georgia Composite Medical Board issued a position statement in May 2026 clarifying that it evaluates physician-oversight relationships based on what’s actually happening in practice, not the formal structure on paper. The Board explicitly rejected the idea that a menu-based drip model with generic, pre-signed orders satisfies physician-supervision requirements — regardless of how the business or contracts are structured. Clinics working with third-party medical-director matching services were specifically flagged for review.
What This Means Even If Your State Hasn’t Acted Yet
If you’re not operating in Texas, Kansas, California, or Georgia, it’s tempting to treat this as someone else’s problem. That’s a risky read of the situation. Regulatory trends in healthcare tend to move state to state once a model is challenged successfully in a few jurisdictions — the Texas legislation in particular is already being referenced as a template elsewhere. Insurance carriers are also part of this shift: several are reportedly narrowing or excluding coverage for clinics still using generic, pre-signed standing orders, regardless of whether that specific state has passed new legislation yet. Your policy can become a liability before your state board does anything at all.
A Quick Self-Check
Before assuming your clinic is fine, ask honestly:
- Does every patient get an individualized assessment by a licensed prescriber before treatment — not just a signed waiver and a menu selection?
- Is your medical director actively involved in reviewing charts and protocols, or is their role effectively limited to an initial signature?
- If you mix additives into IV bags on-site, do you have a pharmacist involved, or are you sourcing pre-mixed products from a licensed facility?
- Has your insurance carrier confirmed in writing that your current standing-order model is still covered under your policy?
- Would your standing orders, if reviewed today by a state board, look individualized — or would they look like the same protocol applied to every patient?
If any of these gave you pause, that’s worth addressing now rather than after an audit, a complaint, or a denied claim forces the issue.
What to Do If You Think You’re Exposed
The fix isn’t necessarily dramatic — most clinics can move toward a compliant model without shutting down. But it does usually require:
- A real review of your current standing orders against your state’s current requirements, not the requirements from when you opened.
- A conversation with your medical director about what active oversight needs to look like going forward, and documentation to prove it’s happening.
- A check with your insurance carrier confirming, in writing, that your current model is covered — before you need to file a claim, not after.
- A plan for individualized assessment at each visit, even if that means restructuring how patients move through your intake process.
None of that requires guessing your way through it alone. This is exactly the kind of question AIVA’s Compliance Corner exists for — a live, ongoing channel to ask attorneys who work specifically in this space whether your current protocols hold up, before a board or a carrier makes that determination for you.
Frequently Asked Questions
Does this affect mobile IV businesses the same way as brick-and-mortar clinics? Generally yes, and in some cases mobile providers face additional scrutiny, since regulators in several states have specifically flagged mobile units operating without real-time physician involvement. The core issue — individualized assessment and active oversight — applies regardless of your physical setup.
If my state hasn’t passed anything like Jenifer’s Law, am I safe? Not necessarily. Absence of new legislation doesn’t mean absence of risk — insurance exclusions and board interpretations can move faster than statutes, and several other states are actively considering similar measures.
Can I keep my current menu of treatments, just with better documentation? In many cases, yes — the treatments themselves usually aren’t the problem. It’s the process around them (individualized assessment, real prescriber involvement per visit, active medical-director oversight) that regulators are focused on.
How do I know if my standing orders would pass a review today? That’s a specific, fact-dependent question that’s worth putting in front of an attorney familiar with IV therapy compliance rather than guessing. AIVA members can submit exactly this kind of question through the Compliance Corner.
Not sure where your clinic stands? Submit your standing orders question to AIVA’s Compliance Corner and get a direct answer from attorneys who work specifically in IV therapy compliance.
Not a member yet? Join AIVA to get ongoing access to compliance guidance, insurance support, and the rest of the resources built for exactly this kind of moment in the industry.